<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/59945A3B-21DF-4F88-8BFC-F95CC2F6E151"><gtr:id>59945A3B-21DF-4F88-8BFC-F95CC2F6E151</gtr:id><gtr:name>Wexner Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D657B59F-F040-46B5-A35B-D457C06CE596"><gtr:id>D657B59F-F040-46B5-A35B-D457C06CE596</gtr:id><gtr:name>Becton, Dickinson and Company (BD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Randall Div of Cell and Molecular Biophy</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/59945A3B-21DF-4F88-8BFC-F95CC2F6E151"><gtr:id>59945A3B-21DF-4F88-8BFC-F95CC2F6E151</gtr:id><gtr:name>Wexner Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D657B59F-F040-46B5-A35B-D457C06CE596"><gtr:id>D657B59F-F040-46B5-A35B-D457C06CE596</gtr:id><gtr:name>Becton, Dickinson and Company (BD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/65EB5007-A4FD-493B-8EA3-3B18BA240012"><gtr:id>65EB5007-A4FD-493B-8EA3-3B18BA240012</gtr:id><gtr:firstName>Jennifer</gtr:firstName><gtr:otherNames>E</gtr:otherNames><gtr:surname>Morgan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/16877DD5-AA60-4A54-B741-134074210F19"><gtr:id>16877DD5-AA60-4A54-B741-134074210F19</gtr:id><gtr:firstName>Juliet</gtr:firstName><gtr:otherNames>Anne</gtr:otherNames><gtr:surname>Ellis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E2431A12-51E3-4F82-B76A-C6822C5869AF"><gtr:id>E2431A12-51E3-4F82-B76A-C6822C5869AF</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>Steven</gtr:otherNames><gtr:surname>Zammit</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0700307"><gtr:id>434DFCB2-88C9-44D8-89C1-FBF97EBED19C</gtr:id><gtr:title>Do lamin A/C and emerin mutations in satellite cells contribute to Emery-Driefuss muscular dystrophy?</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700307</gtr:grantReference><gtr:abstractText>Muscle is made of thousands of muscle fibres, which are repaired and regenerated by muscle stem cells called satellite cells. Muscular dystrophies are a group of inherited disorders that are characterised by progressive muscle weakness and degeneration. Since muscle is responsible for movement, its gradual loss in muscular dystrophies can severely affect the quality of life of a patient, and in some disorders, drastically shorten their lifespan. Compromised satellite cell function is thought to contribute to loss of muscle in some of these conditions, including Emery-Dreifuss muscular dystrophy (EDMD). It has been shown that EDMD is caused by problems in genes that make proteins involved in maintaining a healthy nucleus. We intend to examine satellite cells from patients suffering from EDMD to understand how these mutated proteins affected their function and so muscle repair. We will also use mouse models of the disease to study satellite cell biology. Findings on mouse satellite cells should be broadly applicable to man. Theoretically, manipulation of satellite cells could both augment and prolong muscle function in people with muscular dystrophy, which also has the advantage of maintaining a muscle environment still capable of responding to other forms of therapy.</gtr:abstractText><gtr:technicalSummary>Autosomal Emery-Dreifuss muscular dystrophy (A-EDMD) is caused by mutations in the LMNA gene, that encodes four intermediate filament-like proteins, the major being lamin A and C. Together with B-type lamins, they form part of a proteinaceous network called the nuclear lamina, which underlies the nuclear membrane. EDMD can also be X-linked, in which mutations of the EMD (aka STA) gene are responsible. EMD encodes emerin, an inner nuclear membrane protein, which forms a complex with lamin A/C, cross-linking chromatin, through the nuclear lamina to the inner nuclear membrane. Mutations in LMNA and EMD are thought to result in satellite cell dysfunction. Since satellite cells are the resident stem cells responsible for repair of skeletal muscle, this dysfunction may directly contribute to EDMD. 

Our long-term objective is to understand the role that lamin A/C and emerin plays in satellite cells and how their mutation causes EDMD. Satellite cells from muscles throughout the body will be examined as their heterogeneity could form the basis of different responses of muscle groups to disorders such as EDMD. Expression profiles of these nuclear proteins will be determined in wild-type quiescent satellite cells and during their activation, proliferation, self-renewal and differentiation using immunostaining. Muscle and satellite cells from lamin A/C and emerin null mice will be examined to determine how lack of these proteins affects satellite cell behaviour. Their ability to make muscle and self-renew will also be assayed in vivo using transplantation. Since ~85% of X-linked EDMD result from null mutations in EMD, these studies have direct relevance to the human disorder. 

Mutant proteins in most A-EDMD and ~15% of X-EDMD patients cause a gain or change of function. How these same mutated proteins affect mouse satellite cell behaviour will be examined following viral-mediated delivery. Since human and mouse myoblasts fuse to form mosaic multi-nucleated myotubes, many signalling molecules must interact. Findings on mouse satellite cells therefore, should be broadly applicable to human, but muscle cells obtained from EDMD patients will also be examined for cell cycle and differentiation defects. Theoretically, manipulation of satellite cells could both augment and prolong muscle function in all muscular dystrophies, with the advantage of also maintaining an environment capable of responding to other therapeutic interventions. General principles of satellite cell regulation are also relevant to muscle loss in diseases such as cancer and during aging. This project falls within the musculoskeletal research priority area for PSCSB.</gtr:technicalSummary><gtr:fund><gtr:end>2010-10-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>404198</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Becton, Dickinson and Company (BD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collation and testing of novel LMNA mutations</gtr:description><gtr:id>CF0BD78B-9019-4C4B-989F-3F78CB77D799</gtr:id><gtr:impact>20848652 Scharner Juergen (Feb, 2011) Novel LMNA mutations in patients with Emery-Dreifuss muscular dystrophy and functional characterization of four LMNA mutations., Human mutation 32, 2, 152-67</gtr:impact><gtr:partnerContribution>Provided genetic diagnosis data from patients with suspected EDMD</gtr:partnerContribution><gtr:piContribution>Tested novel LMNA mutations for their effects on myogenic cell nuclear morphology</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biomedical Sciences KCL</gtr:department><gtr:description>Measurement of muscle contraction</gtr:description><gtr:id>9B3D02B3-EADD-4B61-AE4E-59253E2A016D</gtr:id><gtr:impact>21364987 Gnocchi VF, Scharner J, Huang Z, Brady K, Lee JS, White RB, Morgan JE, Sun YB, Ellis JA, Zammit PS (, 2011) Uncoordinated transcription and compromised muscle function in the lmna-null mouse model of Emery- Emery-Dreyfuss muscular dystrophy., PLoS ONE 6, 2,

Multi-disciplinary - combining cell biology and muscle physiology</gtr:impact><gtr:partnerContribution>Allowing force generation in muscles of EDMD mouse models to be measured</gtr:partnerContribution><gtr:piContribution>Supplied EDMD mouse models for measurement of force generation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wexner Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>Collation and testing of novel LMNA mutations II</gtr:description><gtr:id>3CD11D7B-79F0-4137-8C24-931F9DCD0B48</gtr:id><gtr:impact>20848652 Scharner Juergen (Feb, 2011) Novel LMNA mutations in patients with Emery-Dreifuss muscular dystrophy and functional characterization of four LMNA mutations., Human mutation 32, 2, 152-67</gtr:impact><gtr:partnerContribution>Providing novel LMNA mutations for testing</gtr:partnerContribution><gtr:piContribution>Testing the effects of novel LMNA mutations underlying EDMD on myogenic cell nuclei</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Bioinformatics</gtr:description><gtr:id>2919C050-FB34-4A30-A3E6-3FF773DD5E49</gtr:id><gtr:impact>?Scharner, J., Lu, H.-C., Fraternali, F., Ellis, J. A. and Zammit , P. S. (2014). Mapping disease-related missense mutations in the Ig-like fold domain of lamin A/C reveals novel genotype-phenotype associations for laminopathies. Proteins: Structure, Function, and Bioinformatics 82(6):904-15. doi: 10.1002/prot.24465</gtr:impact><gtr:partnerContribution>Provided bioinformatics expertise and software</gtr:partnerContribution><gtr:piContribution>Identifying and locating suitable mutations in LMNA and analysing effects on protein structure, charge and interactions.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physiology, Anatomy and Genetics</gtr:department><gtr:description>Exon-skipping on the LMNA gene</gtr:description><gtr:id>0A7C4411-7495-4F64-9236-06C7B6080123</gtr:id><gtr:impact>Zammit published a paper containing the results of LMNA exon skipping.

? Scharner, J., Figeac, N., Ellis, J.A. and Zammit, P.S. (2015). Ameliorating pathogenesis by removing an exon containing a missense mutation: a potential exon-skipping therapy for laminopathies. Gene Therapy 22, 503-515.</gtr:impact><gtr:partnerContribution>Expertise in exon-skipping and provided the necessary antisense -oligonucleotides for experiments</gtr:partnerContribution><gtr:piContribution>Personnel and animal models to perform the experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Division of Medicine</gtr:department><gtr:description>Making IPS cells</gtr:description><gtr:id>D7D01255-2192-4FA2-B745-DC4EE0A7829F</gtr:id><gtr:impact>Will make IPS cells</gtr:impact><gtr:partnerContribution>Expertise in making IPS cells</gtr:partnerContribution><gtr:piContribution>Contributing EDMD patient cells and helping make IPS</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School outreach</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2225B5BB-F6F2-4D4C-B616-9F5DEFB2ABF1</gtr:id><gtr:impact>~25 6th formers used microscopes to examine muscle tissue and were engaged with the topic generating an active discussion.
100 or so year 7 pupils undertake some histological staining and examine sections under the microscope.

Hopefully an increased level of interest in university and science in general. 

Successful, as will be repeated next year.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Muscular Dystrophy Campaign conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0A29E7FC-99BA-400C-AC19-08C1799F6EA6</gtr:id><gtr:impact>Members of the group gave a talk on muscular dystrophy to the Muscular Dystrophy Campaign's National Conference, to an audience of patients, carers, fund-raisers and supporters.

UK Neuromuscular Translational Research Conference 2016
Patient Day
The Kings Centre, Oxford, OX2 0ES
Monday 22 March 2016


After the talk there was a questions and answers session. Many suffers of muscular dystrophy later commented on how the talk had helped them to understand their condition.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2012,2013,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Muscular Dystrophy Campaign event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AE3B05FA-64A8-49C0-91A0-2C727E5C4BD1</gtr:id><gtr:impact>Muscular Dystrophy Campaign hosted event where researchers spoke of their work and impacts to a lay audience composed of patients, carers, fund-raisers and supporters of the charity. Followed by an active discussion session with the above.

Charity fund-raisers enthused about ongoing research funded by the charity which will hopefully result in increased support for research.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Muscular dystrophy Campaign</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1CBCB77D-B8F6-47BD-820A-76D5F63F0705</gtr:id><gtr:impact>Strategy research meeting to discuss funding priorities.

Prioritization of funding allocation.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Target MDC/MDC website, FSHSoc</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1AE57288-0D79-4E00-AEC9-DFC377809E58</gtr:id><gtr:impact>Regularly edit/contribute articles/quotes to Muscular dystrophy campaign publication (Target MD) and website e.g.
http://www.muscular-dystrophy.org/research/news/2700_new_insight_into_how_muscle_stem_cells_work

Also FSHSoc

url: http://www.fshsociety.org/assets/pdf/FSHSociety_FSHWatch_SummerFall2014.pdf
https://www.fshsociety.org/wp-content/uploads/2014/03/FSH_Society_WATCH_Fall-2015-FINAL-REV1-LR.pdf

Raises awareness of our work (MRC and from other funders) with patients, carers, fund-raisers and stakeholders.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.fshsociety.org/wp-content/uploads/2014/03/FSH_Society_WATCH_Fall-2015-FINAL-REV1-LR.pdf</gtr:url><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC London Interdisciplinary Biosciences PhD Consortium (LIDo)</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>Student rotating in the lab, who then may decide to undertake the PhD.</gtr:fundingRef><gtr:id>864B44F4-2965-4266-9B5A-74FFC18CCD9A</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>77314</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC London Interdisciplinary Biosciences PhD Consortium (LIDo)</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/J014567/1</gtr:fundingRef><gtr:id>198A9CC1-760F-4059-80A0-B578C8786A91</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Muscular Dystrophy Campaign Strategy</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>7E6EA9DC-B9E0-4DF1-89A5-E826BC10A2F9</gtr:id><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Consultant for Pharmaceutical company</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>4118EC3B-7FD1-485B-B504-D97B88F03951</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Novel LMNA mutations published on the http://www.umd.be/ database, allowing rapid confirmation after genetic testing for a diagnosis of EDMD.</gtr:description><gtr:id>856A837D-40A8-4E41-8439-452AC2DAB2E1</gtr:id><gtr:impact>Novel LMNA mutations published on the http://www.umd.be/ database, allowing rapid confirmation after genetic testing of a diagnosis of EDMD.</gtr:impact><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Identification of new LMNA mutations for diagnosis of EDMD</gtr:title><gtr:type>Management of Diseases and Conditions</gtr:type><gtr:url>http://www.umd.be/</gtr:url><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Novel EMD mutations published on the http://www.umd.be/ database, allowing rapid confirmation after genetic testing for a diagnosis of X-EDMD.</gtr:description><gtr:id>4C58EEA2-9176-408E-95A1-757179784135</gtr:id><gtr:impact>Novel EMD mutations published on the http://www.umd.be/ database, allowing rapid confirmation after genetic testing for a diagnosis of X-EDMD.</gtr:impact><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Identification of new EMD mutations for diagnosis of EDMD</gtr:title><gtr:type>Management of Diseases and Conditions</gtr:type><gtr:url>http://www.umd.be/</gtr:url><gtr:yearDevCompleted>2011</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Paper accepted that will then potentially allow patent protection for the sequences involved in exon skipping. 

? Scharner, J., Figeac, N., Ellis, J.A. and Zammit, P.S. (2015). Ameliorating pathogenesis by removing an exon containing a missense mutation: a potential exon-skipping therapy for laminopathies. Gene Therapy 22, 503-515.</gtr:description><gtr:id>82E3ED15-9A0B-4C63-88C6-46292029DB12</gtr:id><gtr:impact>Provides a potential therapy for some laminopathies.

Identifies the potential to treat certain diseases that arise from missense mutations in proteins with structural repeats by exon skipping.</gtr:impact><gtr:stage>Initial development</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Exon skipping sequences</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Collated novel pathogenic EMD mutations from a large American cohort.</gtr:description><gtr:id>DB2D35D4-7172-4B23-BF4D-B702A7313B65</gtr:id><gtr:impact>Increases known mutations underlying X-EDMD significantly Increases the number of mutations in the literature - should help developing better genotype/phenotype correlations. Mutations available at http://www.umd.be/

 21697856 Brown Charlotte A (Aug, 2011) Novel and recurrent EMD mutations in patients with Emery-Dreifuss muscular dystrophy, identify exon 2 as a mutation hot spot., Journal of human genetics 56, 8, 589-94</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Collated novel pathogenic EMD mutations underlying X-EDMD</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.umd.be/</gtr:url><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Found that muscle stem dysfunction could contribute to Emery-Dreifuss Muscular Dystrophy by examining muscle stem cells from mice that are null for the Lmna or Emd genes. Also created new mouse models by crossing these mice with others that have reporter genes expressed in muscle stem cells or myonuclei.</gtr:description><gtr:id>5E512DBF-ABC6-4031-8F36-1C6AFA32EB08</gtr:id><gtr:impact>Provides a methodology that opens a new avenue in understanding of the disease mechanism of EDMD.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Muscle stem cell dysfunction and disease progression</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Lmna constructs lacking exon 5 in retroviral expression vector.</gtr:description><gtr:id>6B1B85A5-E257-46AD-B78C-FF6F1A0AA989</gtr:id><gtr:impact>Allowed us to determine that LMNA lacking amino acids encoded by exon 5 were redundant to LMNA function and so could provide a potential therapy for certain diseases involving missense mutations.

Scharner, J., Figeac, N., Ellis, J.A. and Zammit, P.S. (2015). Ameliorating pathogenesis by removing an exon containing a missense mutation: a potential exon-skipping therapy for laminopathies. Gene Therapy 22, 503-515.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>LMNA exon skipping</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Cloning of pathogenic LMNA mutant species from human patients allows them to be efficiently expressed in cells to determine how they affect cell function.</gtr:description><gtr:id>28300ADC-0598-4B32-AD7A-6D703A0E0A83</gtr:id><gtr:impact>Better understanding of how different mutations in the LMNA gene affect cell function to lead to disease.

Included in 20848652 Scharner Juergen (Feb, 2011) Novel LMNA mutations in patients with Emery-Dreifuss muscular dystrophy and functional characterization of four LMNA mutations., Human mutation 32, 2, 152-67</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Retroviruses containing pathological LMNA species</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Collated new pathological mutations that cause Emery-Dreifuss MD, tested some on cell function in culture. Published in 20848652 Scharner Juergen (Feb, 2011) Novel LMNA mutations in patients with Emery-Dreifuss muscular dystrophy and functional characterization of four LMNA mutations., Human mutation 32, 2, 152-67</gtr:description><gtr:id>41897074-7F63-481C-95F9-9488BED3B17D</gtr:id><gtr:impact>Increases the number of mutations in the literature - should help developing better genotype/phenotype correlations.
Mutations available at http://www.umd.be/</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>New human disease causing LMNA mutations for EDMD published</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.umd.be/</gtr:url><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/50DF6FA0-7849-44D5-AF58-209DF53C7947"><gtr:id>50DF6FA0-7849-44D5-AF58-209DF53C7947</gtr:id><gtr:title>Genotype-phenotype correlations in laminopathies: how does fate translate?</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/57fb0855852bda1a00ecea47b3f901a5"><gtr:id>57fb0855852bda1a00ecea47b3f901a5</gtr:id><gtr:otherNames>Scharner J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EA870521-C9D6-446D-9DD7-997997387E96"><gtr:id>EA870521-C9D6-446D-9DD7-997997387E96</gtr:id><gtr:title>Integrated functions of Pax3 and Pax7 in the regulation of proliferation, cell size and myogenic differentiation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6654a0b045199634457f99036cfedeff"><gtr:id>6654a0b045199634457f99036cfedeff</gtr:id><gtr:otherNames>Collins CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E27A1FF7-0CC5-47A6-9DE3-AB974E90F2E0"><gtr:id>E27A1FF7-0CC5-47A6-9DE3-AB974E90F2E0</gtr:id><gtr:title>Presenilin-1 acts via Id1 to regulate the function of muscle satellite cells in a gamma-secretase-independent manner.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/90aeac0c513710f3f3a92514fb49b9c5"><gtr:id>90aeac0c513710f3f3a92514fb49b9c5</gtr:id><gtr:otherNames>Ono Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7D037B98-EF1D-4F7C-B29A-D04270B13AAE"><gtr:id>7D037B98-EF1D-4F7C-B29A-D04270B13AAE</gtr:id><gtr:title>Defective skeletal muscle growth in lamin A/C-deficient mice is rescued by loss of Lap2a.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aceea0bc85d4abe8108685286289606e"><gtr:id>aceea0bc85d4abe8108685286289606e</gtr:id><gtr:otherNames>Cohen TV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/74E56CB7-879F-45CE-94ED-279FA0BF264B"><gtr:id>74E56CB7-879F-45CE-94ED-279FA0BF264B</gtr:id><gtr:title>Further characterisation of the molecular signature of quiescent and activated mouse muscle satellite cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c458e935294b9a81e76d9b1450594174"><gtr:id>c458e935294b9a81e76d9b1450594174</gtr:id><gtr:otherNames>Gnocchi VF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0FE8441C-3478-4F9F-9FAF-C2AD9C52BF18"><gtr:id>0FE8441C-3478-4F9F-9FAF-C2AD9C52BF18</gtr:id><gtr:title>Identification of an emerin-beta-catenin complex in the heart important for intercalated disc architecture and beta-catenin localisation.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0ac49263d532987a9594ba1e3f6d5a8c"><gtr:id>0ac49263d532987a9594ba1e3f6d5a8c</gtr:id><gtr:otherNames>Wheeler MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2081E74D-69E6-4EED-960F-E965CBE2B5A5"><gtr:id>2081E74D-69E6-4EED-960F-E965CBE2B5A5</gtr:id><gtr:title>Uncoordinated transcription and compromised muscle function in the lmna-null mouse model of Emery- Emery-Dreyfuss muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c458e935294b9a81e76d9b1450594174"><gtr:id>c458e935294b9a81e76d9b1450594174</gtr:id><gtr:otherNames>Gnocchi VF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E699E5F-556D-4B95-8D26-7F67911F3DA9"><gtr:id>1E699E5F-556D-4B95-8D26-7F67911F3DA9</gtr:id><gtr:title>Mapping disease-related missense mutations in the immunoglobulin-like fold domain of lamin A/C reveals novel genotype-phenotype associations for laminopathies.</gtr:title><gtr:parentPublicationTitle>Proteins</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/57fb0855852bda1a00ecea47b3f901a5"><gtr:id>57fb0855852bda1a00ecea47b3f901a5</gtr:id><gtr:otherNames>Scharner J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0887-3585</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B33EA913-1F45-4B62-9D09-200A7DA012AC"><gtr:id>B33EA913-1F45-4B62-9D09-200A7DA012AC</gtr:id><gtr:title>Satellite cells from dystrophic muscle retain regenerative capacity.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/89783a5fcb17bacf0fca3ef2fd51289d"><gtr:id>89783a5fcb17bacf0fca3ef2fd51289d</gtr:id><gtr:otherNames>Boldrin L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ED672E38-E8D7-48CB-9350-3A5263FEFDAA"><gtr:id>ED672E38-E8D7-48CB-9350-3A5263FEFDAA</gtr:id><gtr:title>Novel LMNA mutations in patients with Emery-Dreifuss muscular dystrophy and functional characterization of four LMNA mutations.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/57fb0855852bda1a00ecea47b3f901a5"><gtr:id>57fb0855852bda1a00ecea47b3f901a5</gtr:id><gtr:otherNames>Scharner J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2268C93B-FDF1-4D63-B4AF-CFF999B1EF90"><gtr:id>2268C93B-FDF1-4D63-B4AF-CFF999B1EF90</gtr:id><gtr:title>Ameliorating pathogenesis by removing an exon containing a missense mutation: a potential exon-skipping therapy for laminopathies.</gtr:title><gtr:parentPublicationTitle>Gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/57fb0855852bda1a00ecea47b3f901a5"><gtr:id>57fb0855852bda1a00ecea47b3f901a5</gtr:id><gtr:otherNames>Scharner J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0969-7128</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/01DEC7D8-6C06-4276-9F01-1572160E2A02"><gtr:id>01DEC7D8-6C06-4276-9F01-1572160E2A02</gtr:id><gtr:title>Dynamics of muscle fibre growth during postnatal mouse development.</gtr:title><gtr:parentPublicationTitle>BMC developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e2e673e6fa5ba56052b08f6687490178"><gtr:id>e2e673e6fa5ba56052b08f6687490178</gtr:id><gtr:otherNames>White RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-213X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C259C974-0DA7-4770-9350-0FB881CD7CB8"><gtr:id>C259C974-0DA7-4770-9350-0FB881CD7CB8</gtr:id><gtr:title>Does satellite cell dysfunction contribute to disease progression in Emery-Dreifuss muscular dystrophy?</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c458e935294b9a81e76d9b1450594174"><gtr:id>c458e935294b9a81e76d9b1450594174</gtr:id><gtr:otherNames>Gnocchi VF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C7A20E3C-6B5D-4A5E-A2E3-2B44C451F866"><gtr:id>C7A20E3C-6B5D-4A5E-A2E3-2B44C451F866</gtr:id><gtr:title>Novel and recurrent EMD mutations in patients with Emery-Dreifuss muscular dystrophy, identify exon 2 as a mutation hot spot.</gtr:title><gtr:parentPublicationTitle>Journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9e14ad7dc46751cc03b82cf6e81f69dc"><gtr:id>9e14ad7dc46751cc03b82cf6e81f69dc</gtr:id><gtr:otherNames>Brown CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1434-5161</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0C1FB211-B48E-453D-94E0-93D9BC9A2E22"><gtr:id>0C1FB211-B48E-453D-94E0-93D9BC9A2E22</gtr:id><gtr:title>Therapy in Motion</gtr:title><gtr:parentPublicationTitle>European Biopharmaceutical Review</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/13c4f17632374e89e0e08ae44365cda2"><gtr:id>13c4f17632374e89e0e08ae44365cda2</gtr:id><gtr:otherNames>Ellis Juliet</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700307</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>